TOKYO (Reuters) - Japanese technology investor SoftBank Group ( SFTBF ) has launched a joint venture with Tempus AI ( TEM ) that aims to analyse personal medical data with artificial intelligence (AI) to come up with treatment recommendations.

This is the latest in a string of AI investments SoftBank has recently announced as it increases the pace of its investment activity after a muted few years.

SoftBank invested around $200 million in Tempus in its series G funding round in April before Tempus listed on the Nasdaq in June.

($1 = 160.4700 yen)

(This story has been corrected to say that Tempus AI ( TEM ) listed in June, not May, in paragraph 3)